Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults. Preprint
GHDx Entry last modified on: May 12, 2022
Blood tests
Dataset Records for Blood tests
Displaying 101 - 150 of 1718
SARS-CoV-2 seroprevalence and characteristics of post-infection immunity in a general population cohort study in Catalonia, Spain. Preprint
GHDx Entry last modified on: May 12, 2022
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Preprint
GHDx Entry last modified on: Oct 6, 2022
Ireland Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI) 2020
Survey:
Epi surveillance
Presence of antibodies against SARS-CoV-2 in the district area Rinkeby-Kista, Stockholm, 22–24 June 2020
Förekomsten av antikroppar mot SARS-CoV-2 i stadsdelsområdet Rinkeby-Kista, Stockholm, 22–24 juni 2020
Survey:
Community - Cross-sectional - Exam - Urban only
Montenegro Institute of Public Health COVID-19 Dashboard June 2020
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
GHDx Entry last modified on: Dec 11, 2023
Afghanistan National COVID-19 Prevalence and Related Deaths Survey 2020
National Survey of Prevalence of COVID-19 and its Related Deaths in Afghanistan
Survey:
Cross-sectional - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
SARS-CoV-2 antibody prevalence and symptoms in a local Austrian population. Preprint
GHDx Entry last modified on: Mar 14, 2022
[Minsa publishes technical data of the study that reveals that 25.3% of Lima and Callao acquired COVID-19]
Minsa divulga ficha técnica del estudio que revela que el 25.3% de Lima y Callao adquirió el COVID-19
Survey:
Epi surveillance
Sero-prevalence of SARS-CoV-2 Antibody Among Adults in the General Population in Diredawa, Ethiopia. Preprint
GHDx Entry last modified on: Sep 13, 2022
COVID-19: around 35 000 people have been tested
GHDx Entry last modified on: Feb 10, 2022
India - Kerala COVID 19 Sero Surveillance Report August - September 2021
COVID 19 Sero Surveillance Report
Survey:
Cross-sectional - Epi surveillance
Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
Canada - Quebec COVID-19 First Wave Blood Donor Seroprevalence Study 2020
Étude De Séroprévalence Des Anti-Sras-Cov-2 Chez Les Donneurs De Sang D’héma-Québec, Vers La Fin De La Première Vague De Covid-19
Survey:
Epi surveillance
Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China
GHDx Entry last modified on: Mar 14, 2022
Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS CoV-2 Serosurvey in Addis Ababa, Ethiopia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Anti-SARS-CoV-2 IgG antibodies in adolescent students and their teachers in Saxony, Germany (SchoolCoviDD19): very low seropraevalence and transmission rates. Preprint
GHDx Entry last modified on: Mar 14, 2022
Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders. Preprint
GHDx Entry last modified on: Mar 14, 2022
Phase 2 of Sero Survey Begins in Latehar, Simdega, Pakur
GHDx Entry last modified on: Feb 10, 2022
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context. Preprint
COVID-19 em uma Região Metropolitana: vulnerabilidade social e políticas públicas em contextos de desigualdades
CDC COVID Data Tracker Commercial Laboratory Seroprevalence Survey Data 2020-2022
Survey:
Epi surveillance - Individual - Subnationally representative
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
GHDx Entry last modified on: Mar 14, 2022
Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany. Preprint
GHDx Entry last modified on: Mar 14, 2022
Denmark Blood Donors are Now Being Re-examined for Coronavirus Infection
Survey:
Epi surveillance
Estonia COVID-19 Coronavirus prevalence study 2020-2023
Koroonaviiruse levimuse uuring "Covid-19 aktiivne seire"
Survey:
Epi surveillance
Canada COVID-19 Seroprevalence Report - April 2020 to January 2021
COVID-19 Public Seroprevalence Report April 2020 to January 2021
Epi surveillance:
Nationally representative
Sero-prevalence of anti-SARS-CoV-2 Antibodies in Addis Ababa, Ethiopia. Preprint
GHDx Entry last modified on: Mar 14, 2022
A COVID-19 Hotspot Area: Activities and Epidemiological Findings
GHDx Entry last modified on: Mar 14, 2022
England - Coronavirus (COVID-19) Infection Survey: Antibody Data, January 2021
Coronavirus (COVID-19) Infection Survey: antibody data for the UK, January 2021
Survey:
Epi surveillance
Seroprevalence of COVID-19 virus infection in Guilan province, Iran. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors. Preprint
GHDx Entry last modified on: Mar 14, 2022
Scotland Enhanced Surveillance of Covid-19 Dashboard 2020-2022
Enhanced Surveillance of Covid-19 in Scotland (Population-based seroprevalence)
Epi surveillance:
Epi surveillance
Spain - National Study of Sero-epidemiology of Infection by Sars-Cov-2 2020
Estudio Nacional de Sero-epidemiología de la Infección por Sars-Cov-2 en España
Survey:
Exam - Household - Interview - Longitudinal
Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic
GHDx Entry last modified on: Mar 14, 2022
France COVID-19 Epidemic Monitoring Dashboard 2020-2022
Tableau de bord COVID-19 Suivi de l’épidémie de COVID-19 en France
Detection of Antibodies After Review of Covid-19 in Blood Donors (Sub-report 2)
Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 2)
Survey:
Epi surveillance
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020
GHDx Entry last modified on: Mar 14, 2022
Canada COVID-19 Seroprevalence Report - January 12, 2021
COVID-19 Seroprevalence Report January 12, 2021 - Report #4: November 2020 Survey
Canada COVID-19 Seroprevalence Report - December 18, 2020
COVID-19 Seroprevalence Report December 18, 2020 - Report #3: October 2020 Survey
Germany - Saarland antibody study on coronavirus infection completed: Institute for Virology at Saarland University Hospital presents results
GHDx Entry last modified on: Feb 10, 2022
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
GHDx Entry last modified on: Mar 14, 2022
Subscribe